Exclusive - Study Measures CBN vs Melatonin: The New Sleep Solution Showdown
Arcview
Thu, Jun 29
FloraWorks Holdings, a cannabinoid therapeutics firm, has disclosed groundbreaking results from the first-ever double-blind, randomized, placebo-controlled trial for its prime offering, TruCBN,...
Discover